Log In
Print
BCIQ
Print
Print this Print this
 

Rebetol, ribavirin

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCombination of intron A interferon (IFN) alfa-2b and ribavirin
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionType I interferon (IFN) receptor agonist
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C virus (HCV) infection; Treat hepatitis C virus (HCV) and HIV co-infections
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today